Literature DB >> 4195058

Treatment of Gilbert's syndrome with phenobarbitone.

M Black, S Sherlock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4195058     DOI: 10.1016/s0140-6736(70)91269-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  Population studies on Gilbert's syndrome.

Authors:  D Owens; J Evans
Journal:  J Med Genet       Date:  1975-06       Impact factor: 6.318

2.  The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs.

Authors:  A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

3.  An expanded model of bilirubin kinetics: effect of feeding, fasting, and phenobarbital in Gilbert's syndrome.

Authors:  G Kirshenbaum; D M Shames; R Schmid
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

Review 4.  New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias.

Authors:  P Berthelot; D Dhumeaux
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

5.  Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphenylhydantoin administration.

Authors:  J L Cunningham; D A Evans
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

6.  Unconjugated hyperbilirubinaemia in achalasia.

Authors:  J Fevery; K P Heirwegh; J De Groote
Journal:  Gut       Date:  1974-02       Impact factor: 23.059

7.  The use of jejunal transplants to treat a genetic enzyme deficiency.

Authors:  B M Jaffe; A A Burgos; M Martinez-Noack
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

8.  Estimation of hepatic bilirubin UDP-glucuronyl transferase in patients with noncirrhotic portal fibrosis and liver disease: Significance and limitations.

Authors:  D V Datta; R Nair; C R Nair
Journal:  Am J Dig Dis       Date:  1975-10

9.  Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis.

Authors:  B W Trotman; L Shaw; J Roy-Chowdhury; P F Malet; E F Rosato
Journal:  Dig Dis Sci       Date:  1983-08       Impact factor: 3.199

10.  Controlled trial of phetharbital, a non-hypnotic barbiturate, in unconugated hyperbilirubinaemia.

Authors:  J Hunter; R P Thompson; M O Rake; R Williams
Journal:  Br Med J       Date:  1971-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.